MedPath

Treatment of pimples on the face

Not Applicable
Conditions
Health Condition 1: L700- Acne vulgaris
Registration Number
CTRI/2023/07/054885
Lead Sponsor
Dr Mahima Arora
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

A written consent for participation in the study.

Patients having moderate to severe acne vulgaris.

Exclusion Criteria

Age less than 15 years.

Patients having mild facial acne vulgaris, papulopustular rosacea.

Married female, pregnant women and women who intend to became pregnant during the course of treatment, lactating mothers.

History of macrolide sensitization, having polycystic ovary.

Presence of renal and hepatic derangement, pre-existing hyperlipidemia, past history of photosensitivity, allergic reaction to the prescribed drugs.

Presence of systemic disease.

Drug induced acneiform eruptions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the effect of combining oral isotretinoin to azithromycin pulse therapy in treatment of <br/ ><br>acne lesions. <br/ ><br>To compare the efficacy & safety of oral isotretinoin alone vs oral isotretinoin with azithromycin <br/ ><br>pulse therapy in the treatment of moderate to severe acne vulgaris.Timepoint: 2 weeks, 4 weeks, 6 weeks, 8weeks , 10 weeks, 12 weeks <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To compare the efficacy & safety of oral isotretinoin alone vs oral isotretinoin with azithromycin pulse therapy in the treatment of moderate to severe acne vulgaris.Timepoint: 2 weeks, 4 weeks, 6 weeks, 8weeks , 10 weeks, 12 weeks
© Copyright 2025. All Rights Reserved by MedPath